Links to articles in the current and previous 2 issues of this bulletin are displayed below.
To receive email notifications about new issues of this bulletin, please email: richard.fallis@healthcarelibrary.qub.ac.uk
Advances in RNA editing in hematopoiesis and associated malignancies
Allogeneic hematopoietic cell transplantation for acute myeloid leukemia in adults over 70 years old
Approaching a therapeutic inflection point for FLT3-mutated AML
Artificial intelligence in haematopathology: current perspective and future directions
Blood under pressure: how climate change threatens blood safety and supply chains
Chronic myeloid leukemia: a review (JAMA)
Clonal hematopoiesis landscape in frequent blood donors
Debating race and the diagnosis of anemia — how medicine moved away from race-based standards
Decoding functional hematopoietic progenitor cells in the adult human lung
EMZL at various sites: learning from each other
Endothelial dysfunction in patients with type 2 diabetes: the truth is in the blood
How I approach pharmacological thromboprophylaxis in children
How I diagnose and treat cardiorespiratory complications of transfusion
How I manage pregnant patients who are alloimmunized to RBC antigens
How I treat AML relapse after allogeneic HSCT
How I treat challenging transfusion cases in sickle cell disease
How I treat patients who are refractory to platelet transfusions
How I use noninvasive prenatal testing for red blood cell and platelet antigens
Identification of hepatic-like EPO as a cause of polycythemia
Immunoactinopathies revisited: understanding clinical manifestations and biological pathway
Iron deficiency in adults: a review (JAMA)
Ph-positive acute lymphoblastic leukemia — 25 years of progress
Sustained clinical benefit of AAV gene therapy in severe hemophilia B
TP53-mutated acute myeloid leukemia: how can we improve outcomes?
Vaccines for preventing infections in adults with haematological malignancies (new Cochrane intervention review)
Blood (1st May-12th June); Cochrane Library (May-Jun); Diagnostic Histopathology (May); JAMA (May); Journal of Clinical Investigation, The (May); Lancet Planetary Health, The (Apr); NEJM (Apr-Jun)
Blinatumomab with chemotherapy for consolidation treatment of Philadelphia-chromosome-negative CD19-positive minimal residual disease-negative B-cell precursor acute lymphoblastic leukaemia (new NICE guideline TA1049)
Classification and risk stratification in T-lineage acute lymphoblastic leukemia
The contribution of the monocyte-macrophage lineage to immunotherapy outcomes
Don't break the (blood) bank: can waste be minimized in a whole blood program?
Essential thrombocythemia: a review
The evolution of treatment-free remission
FDA-approved therapies for chronic GVHD
Genetic subtypes of B-cell acute lymphoblastic leukemia in adults
Haemophilia (Lancet seminar)
Honing CAR T cells to tackle acute myeloid leukemia
How I diagnose and treat acute infection–associated purpura fulminans
How I manage patients with unexplained cytopenia
How I treat acute myeloid leukemia with differentiation therapy
How I treat patients with AML using azacitidine and venetoclax
How I treat quantitative fibrinogen disorders
How I treat secondary acute myeloid leukemia
How I use maintenance therapy in acute myeloid leukemia
Illustrated capsules from the Advanced Course in Platelet Research
Impact of new medications on the treatment of immune TTP
Long-term outcomes of tyrosine kinase inhibitors in chronic myeloid leukemia
Novel treatment strategies for chronic myeloid leukemia
The present and future of CAR T-cell therapy for adult B-cell ALL
Red blood cell transfusion management for people undergoing cardiac surgery for congenital heart disease (new Cochrane intervention review)
The United Kingdom Infected Blood Inquiry: its findings and lessons for the future of transfusion
American Journal of Surgery (Feb); Blood (20th Feb - 10th Apr); Cochrane Library (Mar-Apr); JAMA (Feb); Lancet, The (Mar); NICE website (Mar); Research and Practice in Thrombosis and Haemostasis (Feb)
Acute promyelocytic leukemia: long-term outcomes from the HARMONY project
Andexanet alfa for reversing anticoagulation from apixaban or rivaroxaban (updated NICE guideline TA697)
β-Thalassemia minor is associated with high rates of worsening anemia in pregnancy
Building the future management of follicular lymphoma with T-cell–redirecting strategies
Cost-effectiveness of iptacopan for paroxysmal nocturnal hemoglobinuria
The current landscape of frontline large B-cell lymphoma trials
Current myeloproliferative neoplasm scoring systems for clinical practice
Frontline management of mantle cell lymphoma
High-risk MCL: recognition and treatment
How I treat/manage:
Management of iron overload: lessons from transfusion-dependent hemoglobinopathies
Menin inhibitors in the treatment of acute myeloid leukemia
Prothrombotic antibodies targeting the spike protein's receptor-binding domain in severe COVID-19
Transfusion of blood and blood products for the management of postpartum haemorrhage (new Cochrane intervention review)
Treatment of relapsed/refractory MCL
Unraveling MCL biology to understand resistance and identify vulnerabilities
Vadadustat for treating symptomatic anaemia in adults having dialysis for chronic kidney disease (new NICE guideline TA1035
Blood (Jan-13th Feb); Cochrane Library (Feb); Journal of Pain and Symptom Management (Jan); NICE website (Jan-Feb)
The Healthcare Library cannot guarantee the correctness or completeness of the information in these bulletins. The information is subject to change and we cannot guarantee it will remain up-to-date. It is your responsibility to check the accuracy and validity of the information. These bulletins are the property of the Healthcare Library; please credit us if re-using or distributing content from them.